Quick summary: Probiotic Blister: Out of Specification. Date: 2023-03-01.
Public recall detail
Probiotic Blister: Out of Specification
2023-03-01
Recall
Safety notice
Quick summary
Recommended action
Recommended action: compare your product with the official notice and follow the instructions published by the official source.
Recall details
Quick summary: Probiotic Blister: Out of Specification. Date: 2023-03-01.
Official details
Affected product details
Structured information extracted from the official recall notice. Confirm the identifiers and instructions in the original notice.
BrandProbiotic Blister
ProductProbiotic Blister
IssueHealth products - Product quality
Recall classType II
IdentificationRA-73064
Affected products
BrandProbiotic Blister
ProductProbiotic 50 billion
DIN / NPN / authorizationNPN 80083913
Dosage formCapsule
StrengthBifidobacterium animalis subsp. lactis 15 billion CFU, Bifidobacterium bifidum 1 billion CFU, Bifidobacterium longum subsp. longum 1.5 billion CFU, Lacticaseibacillus paracasei 2.5 billion CFU, Lactiplantibacillus plantarum 2.5 billion CFU, Lactobacillus acidophilus 2.5 billion CFU, Lactobacillus casei 2 billion CFU, Lactobacillus gasseri 2.5 billion CFU, Lactobacillus reuteri 0.5 billion CFU, Lactobacillus rhamnosus 20 billion CF
LotVA269
Issue
Bacteria content is below specification in the affected lot.
What you should do
- Verify if your product is affected.
- Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
- Contact the recalling firm if you have any questions about the recall.
- Report any health product related side effects to Health Canada.
- Report any other health product safety complaints to Health Canada.
Additional official information
AudienceGeneral public Healthcare Industry
CategoryHealth products - Natural health products
CompaniesJamp Pharma Corporation 1310 Rue Nobel Boucherville, QC J4B 5H3
Published byHealth Canada
Recall classType II
Alert / recall typeHealth product recall
Identification numberRA-73064
Background{}
CompaniesJamp Pharma Corporation 1310 Rue Nobel Boucherville, QC J4B 5H3
AudiencesGeneral public Healthcare Industry
Source updated2023-03-01
Contains information licensed under the Open Government Licence – Canada. SafetyPulse is independent of the Government of Canada.
FAQ
Frequently asked questions
Answers based on the official recall notice.
Product images
Official product images from Health Canada.
Starting...
Explore more
Related recalls
Similar recalls and safety notices.